Metabolic triggered inflammation in osteoarthritis

Osteoarthritis and Cartilage

Volumn 23, Issue 1, 2015, Pages 22-30

  Wang, X ^a   Hunter, D ^b   Xu, J ^c   Ding, C ^a,b,c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Metabolic factors; Obesity; Osteoarthritis

Indexed keywords

ADALIMUMAB; ADIPOCYTOKINE; ADIPONECTIN; AMG 108; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CYTOKINE; DIACEREIN; LEPTIN; MICRORNA; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VITAMIN D;

BODY FAT; BODY MASS; DISEASE ASSOCIATION; EXERCISE; HUMAN; METABOLIC DISORDER; METABOLIC TRIGGERED INFLAMMATION; NONHUMAN; NUTRIENT; OBESITY; OSTEOARTHRITIS; REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ADIPOKINES; CYTOKINES; HUMANS; INFLAMMATION; OSTEOARTHRITIS;

EID: 84918821685     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.10.002     Document Type: Review

References (105)

1. Hootman J.M., Helmick C.G. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006, 54(1):226-229.
2. Blagojevic M., Jinks C., Jeffery A., Jordan K.P. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010, 18(1):24-33.
3. Zhuo Q., Yang W., Chen J., Wang Y. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol 2012, 8(12):729-737.
4. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
5. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867.
6. Monteiro R., Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm 2010, 2010.
7. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11(2):85-97.
8. Emanuela F., Grazia M., Marco de R., Maria Paola L., Giorgio F., Marco B. Inflammation as a link between obesity and metabolic syndrome. JNutr Metab 2012, 2012:476380.
9. Zeyda M., Farmer D., Todoric J., Aszmann O., Speiser M., Gyori G., et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes 2007, 31(9):1420-1428.
10. Epstein F.H., Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. NEngl J Med 1999, 340(6):448-454.
11. Lenders C.M., Feldman H.A., Von Scheven E., Merewood A., Sweeney C., Wilson D.M., et al. Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr 2009, 90(3):459-467.
12. Ding C., Parameswaran V., Blizzard L., Burgess J., Jones G. Not a simple fat-soluble vitamin: changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults. JIntern Med 2010, 268(5):501-510.
13. Xie H., Lim B., Lodish H.F. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009, 58(5):1050-1057.
14. Ding C., Parameswaran V., Cicuttini F., Burgess J., Zhai G., Quinn S., et al. Association between leptin, body composition, sex and knee cartilage morphology in older adults: the Tasmanian older adult cohort (TASOAC) study. Ann Rheum Dis 2008, 67(9):1256-1261.
15. Ding C., Cicuttini F., Scott F., Cooley H., Jones G. Knee structural alteration and BMI: a cross-sectional study. Obes Res 2005, 13(2):350-361.
16. Teichtahl A.J., Wang Y., Wluka A.E., Cicuttini F.M. Obesity and knee osteoarthritis: new insights provided by body composition studies. Obesity (Silver Spring) 2008, 16(2):232-240.
17. Sowers M., Yosef M., Jamadar D., Jacobson J., Karvonen-Gutierrez C., Jaffe M. BMI vs. body composition and radiographically defined osteoarthritis of the knee in women: a 4-year follow-up study. Osteoarthritis Cartilage 2008, 16(3):367-372.
18. Ding C., Stannus O., Cicuttini F., Antony B., Jones G. Body fat is associated with increased and lean mass with decreased knee cartilage loss in older adults: a prospective cohort study. Int J Obes 2013, 37(6):822-827.
19. Teichtahl A.J., Wang Y., Wluka A.E., Szramka M., English D.R., Giles G.G., et al. The longitudinal relationship between body composition and patella cartilage in healthy adults. Obesity (Silver Spring) 2008, 16(2):421-427.
20. Berry P.A., Wluka A.E., Davies-Tuck M.L., Wang Y., Strauss B.J., Dixon J.B., et al. The relationship between body composition and structural changes at the knee. Rheumatol (Oxford) 2010, 49(12):2362-2369.
21. Ding C., Stannus O., Antony B., Cicuttini F., Jones G. Body fat and lean mass have opposite effects on loss of knee cartilage and increase in knee pain in older adults: a prospective cohort study. Osteoarthritis Cartilage 2012, 20:S21.
22. Clockaerts S., Bastiaansen-Jenniskens Y.M., Runhaar J., Van Osch G.J., Van Offel J.F., Verhaar J.A., et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 2010, 18(7):876-882.
23. Han W., Cai S., Liu Z., Jin X., Wang X., Antony B., et al. Infrapatellar fat pad in the knee: is local fat good or bad for knee osteoarthritis?. Arthritis Res Ther 2014, 16(4):R145.
24. Gomez R., Conde J., Scotece M., Gomez-Reino J.J., Lago F., Gualillo O. What's new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol 2011, 7(9):528-536.
25. de Boer T., Van Spil W., Huisman A., Polak A., Bijlsma J., Lafeber F., et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage 2012, 20(8):846-853.
26. Masuzaki H., Ogawa Y., Isse N., Satoh N., Okazaki T., Shigemoto M., et al. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995, 44(7):855-858.
27. Vuolteenaho K., Koskinen A., Nieminen R., Moilanen T., Moilanen E. Leptin enhances MMP-1 MMP-3 and MMP-13 production in human osteoarthritis cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin Exp Rheumatol 2011, 29(1):57-64.
28. Vuolteenaho K., Koskinen A., Kukkonen M., Nieminen R., Paivarinta U., Moilanen T., et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage-mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm 2009, 2009:345838.
29. Bao J.P., Chen W.P., Feng J., Hu P.F., Shi Z.L., Wu L.D. Leptin plays a catabolic role on articular cartilage. Mol Biol Rep 2010, 37(7):3265-3272.
30. Griffin T.M., Huebner J.L., Kraus V.B., Guilak F. Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum 2009, 60(10):2935-2944.
31. Stannus O.P., Jones G., Quinn S.J., Cicuttini F.M., Dore D., Ding C. The association between leptin, interleukin-6, and hip radiographic osteoarthritis in older people: a cross-sectional study. Arthritis Res Ther 2010, 12(3):R95.
32. Stannus O.P., Cao Y., Antony B., Blizzard L., Cicuttini F., Jones G., et al. Cross-sectional and longitudinal associations between circulating leptin and knee cartilage thickness in older adults. Ann Rheum Dis 2013 Sep 27, [Epub ahead of print]. 10.1136/annrheumdis-2013-203308.
33. Lubbeke A., Finckh A., Puskas G.J., Suva D., Ladermann A., Bas S., et al. Do synovial leptin levels correlate with pain in end stage arthritis?. Int Orthop 2013, 37(10):2071-2079.
34. Dumond H., Presle N., Terlain B., Mainard D., Loeuille D., Netter P., et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003, 48(11):3118-3129.
35. Karvonen-Gutierrez C.A., Sowers M.R., Heeringa S.G. Sex dimorphism in the association of cardiometabolic characteristics and osteophytes-defined radiographic knee osteoarthritis among obese and non-obese adults: NHANES III. Osteoarthritis Cartilage 2012, 20(7):614-621.
36. Kang E.H., Lee Y.J., Kim T.K., Chang C.B., Chung J.H., Shin K., et al. Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res Ther 2010, 12(6):R231.
37. Chen T.H., Chen L., Hsieh M.S., Chang C.P., Chou D.T., Tsai S.H. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 2006, 1762(8):711-718.
38. Yusuf E., Ioan-Facsinay A., Bijsterbosch J., Klein-Wieringa I., Kwekkeboom J., Slagboom P.E., et al. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann Rheum Dis 2011, 70(7):1282-1284.
39. Gandhi R., Takahashi M., Smith H., Rizek R., Mahomed N.N. The synovial fluid adiponectin-leptin ratio predicts pain with knee osteoarthritis. Clin Rheumatol 2010, 29(11):1223-1228.
40. Lago R., Gomez R., Otero M., Lago F., Gallego R., Dieguez C., et al. Anew player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 2008, 16(9):1101-1109.
41. Koskinen A., Juslin S., Nieminen R., Moilanen T., Vuolteenaho K., Moilanen E. Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther 2011, 13(6):R184.
42. Francin P.J., Abot A., Guillaume C., Moulin D., Bianchi A., Gegout-Pottie P., et al. Association between adiponectin and cartilage degradation in human osteoarthritis. Osteoarthritis Cartilage 2014, 22(3):519-526.
43. Zhang Z., Xing X., Hensley G., Chang L.W., Liao W., Abu-Amer Y., et al. Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum 2010, 62(7):1993-2003.
44. Yang S., Ryu J.H., Oh H., Jeon J., Kwak J.S., Kim J.H., et al. NAMPT (visfatin), a direct target of hypoxia-inducible factor-2alpha, is an essential catabolic regulator of osteoarthritis. Ann Rheum Dis 2013 Dec 17, [Epub ahead of print]. 10.1136/annrheumdis-2013-204355.
45. Valcamonica E., Chighizola C.B., Comi D., De Lucia O., Pisoni L., Murgo A., et al. Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis. Clin Exp Rheumatol 2014, 32(2):243-250.
46. Lago F., Dieguez C., Gomez-Reino J., Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007, 3(12):716-724.
47. Hashimoto M., Nakasa T., Hikata T., Asahara H. Molecular network of cartilage homeostasis and osteoarthritis. Med Res Rev 2008, 28(3):464-481.
48. Hoff P., Buttgereit F., Burmester G.R., Jakstadt M., Gaber T., Andreas K., et al. Osteoarthritis synovial fluid activates pro-inflammatory cytokines in primary human chondrocytes. Int Orthop 2013, 37(1):145-151.
49. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7(1):33-42.
50. Richter F., Natura G., Ebbinghaus M., von Banchet G.S., Hensellek S., Konig C., et al. Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum 2012, 64(12):4125-4134.
51. Livshits G., Zhai G., Hart D.J., Kato B.S., Wang H., Williams F.M., et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford Study. Arthritis Rheum 2009, 60(7):2037-2045.
52. Stannus O., Jones G., Cicuttini F., Parameswaran V., Quinn S., Burgess J., et al. Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010, 18(11):1441-1447.
53. Stannus O.P., Jones G., Blizzard L., Cicuttini F.M., Ding C. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis 2013, 72(4):535-540.
54. Chen B., Deng Y., Tan Y., Qin J., Chen L.B. Association between severity of knee osteoarthritis and serum and synovial fluid interleukin 17 concentrations. JInt Med Res 2014, 42(1):138-144.
55. Denoble A.E., Huffman K.M., Stabler T.V., Kelly S.J., Hershfield M.S., McDaniel G.E., et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci USA 2011, 108(5):2088-2093.
56. Helmark I.C., Mikkelsen U.R., Borglum J., Rothe A., Petersen M.C., Andersen O., et al. Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial. Arthritis Res Ther 2010, 12(4):R126.
57. Choi J., Joseph L., Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 2013, 14(3):232-244.
58. Kaptoge S., Di Angelantonio E., Pennells L., Wood A.M., White I.R., Gao P., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. NEngl J Med 2012, 367(14):1310-1320.
59. Hanna F.S., Bell R.J., Cicuttini F.M., Davison S.L., Wluka A.E., Davis S.R. High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther 2008, 10(1):R27.
60. Pearle A.D., Scanzello C.R., George S., Mandl L.A., DiCarlo E.F., Peterson M., et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007, 15(5):516-523.
61. Jin X., Beguerie J., Zhang W., Blizzard L., Otahal P., Jones G., et al. Circulating C-reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2014, 72. accepted.
62. Happonen K.E., Heinegard D., Saxne T., Blom A.M. Interactions of the complement system with molecules of extracellular matrix: relevance for joint diseases. Immunobiology 2012, 217(11):1088-1096.
63. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17(12):1674-1679.
64. Scott J.L., Scanzello C.R., Dragomir C., Crow M.K. Complement activation and regulation in early and advanced stage osteoarthritis. Ann Rheum Dis 2011, 69(Suppl 2). A37-A.
65. Masuko K., Murata M., Suematsu N., Okamoto K., Yudoh K., Nakamura H., et al. Ametabolic aspect of osteoarthritis: lipid as a possible contributor to the pathogenesis of cartilage degradation. Clin Exp Rheumatol 2009, 27(2):347-353.
66. Tiku M.L., Shah R., Allison G.T. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. JBiol Chem 2000, 275(26):20069-20076.
67. Tsezou A., Iliopoulos D., Malizos K.N., Simopoulou T. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. JOrthop Res 2010, 28(8):1033-1039.
68. Gkretsi V., Simopoulou T., Tsezou A. Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog Lipid Res 2011, 50(2):133-140.
69. Davies-Tuck M.L., Hanna F., Davis S.R., Bell R.J., Davison S.L., Wluka A.E., et al. Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther 2009, 11(6):R181.
70. Dore D., de Hoog J., Giles G., Ding C., Cicuttini F., Jones G. Alongitudinal study of the association between dietary factors, serum lipids, and bone marrow lesions of the knee. Arthritis Res Ther 2012, 14(1):R13.
71. Wu C.L., Jain D., McNeill J.N., Little D., Anderson J.A., Huebner J.L., et al. Dietary fatty acid content regulates wound repair andthe pathogenesis of osteoarthritis following joint injury. Ann Rheum Dis 2014 July 10, [Epub ahead of print]. 10.1136/annrheumdis-2014-205601.
72. Baker K.R., Matthan N.R., Lichtenstein A.H., Niu J., Guermazi A., Roemer F., et al. Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study. Osteoarthritis Cartilage 2012, 20(5):382-387.
73. Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad Med J 2012, 88(1038):240-242.
74. Hiraiwa H., Sakai T., Mitsuyama H., Hamada T., Yamamoto R., Omachi T., et al. Inflammatory effect of advanced glycation end products on human meniscal cells from osteoarthritic knees. Inflamm Res 2011, 60(11):1039-1048.
75. Davies-Tuck M.L., Wang Y., Wluka A.E., Berry P.A., Giles G.G., English D.R., et al. Increased fasting serum glucose concentration is associated with adverse knee structural changes in adults with no knee symptoms and diabetes. Maturitas 2012, 72(4):373-378.
76. Ding C., Cicuttini F., Parameswaran V., Burgess J., Quinn S., Jones G. Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the Tasmanian older adult cohort study. Arthritis Rheum 2009, 60(5):1381-1389.
77. Heidari B., Heidari P., Hajian-Tilaki K. Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop 2011, 35(11):1627-1631.
78. Laslett L.L., Quinn S., Burgess J.R., Parameswaran V., Winzenberg T.M., Jones G., et al. Moderate vitamin D deficiency is associated with changes in knee and hip pain in older adults: a 5-year longitudinal study. Ann Rheum Dis 2013, 73(4):697-703.
79. Heneghan H.M., Miller N., Kerin M.J. Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 2010, 11(5):354-361.
80. Kloting N., Berthold S., Kovacs P., Schon M.R., Fasshauer M., Ruschke K., et al. MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 2009, 4(3):e4699.
81. Iliopoulos D., Malizos K.N., Oikonomou P., Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008, 3(11):e3740.
82. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009, 60(9):2723-2730.
83. Yamasaki K., Nakasa T., Miyaki S., Ishikawa M., Deie M., Adachi N., et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009, 60(4):1035-1041.
84. Vonk L.A., Kragten A.H., Dhert W.J., Saris D.B., Creemers L.B. Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. Osteoarthritis Cartilage 2013, 21(1):145-153.
85. Messier S.P., Mihalko S.L., Legault C., Miller G.D., Nicklas B.J., DeVita P., et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA 2013, 310(12):1263-1273.
86. Miller G.D., Jenks M.Z., Vendela M., Norris J.L., Muday G.K. Influence of weight loss, body composition, and lifestyle behaviors on plasma adipokines: a randomized weight loss trial in older men and women with symptomatic knee osteoarthritis. JObes 2012, 2012:708505.
87. Richette P., Poitou C., Garnero P., Vicaut E., Bouillot J.L., Lacorte J.M., et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 2011, 70(1):139-144.
88. Nicklas B.J., Ambrosius W., Messier S.P., Miller G.D., Penninx B.W., Loeser R.F., et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 2004, 79(4):544-551.
89. Durmus D., Alayli G., Aliyazicioglu Y., Buyukakincak O., Canturk F. Effects of glucosamine sulfate and exercise therapy on serum leptin levels in patients with knee osteoarthritis: preliminary results of randomized controlled clinical trial. Rheumatol Int 2013, 33(3):593-599.
90. Chevalier X., Goupille P., Beaulieu A.D., Burch F.X., Bensen W.G., Conrozier T., et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009, 61(3):344-352.
91. Cohen S.B., Proudman S., Kivitz A.J., Burch F.X., Donohue J.P., Burstein D., et al. Arandomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011, 13(4):R125.
92. Fidelix T.S., Macedo C.R., Maxwell L.J., Fernandes Moca Trevisani V. Diacerein for osteoarthritis. Cochrane Database Syst Rev 2014, 2:CD005117.
93. Chevalier X., Ravaud P., Maheu E., Baron G., Rialland A., Vergnaud P., et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Ann Rheum Dis 2014 May 9, [Epub ahead of print]. 10.1136/annrheumdis-2014-205348.
94. Verbruggen G., Wittoek R., Vander Cruyssen B., Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 2012, 71(6):891-898.
95. Maksymowych W.P., Russell A.S., Chiu P., Yan A., Jones N., Clare T., et al. Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther 2012, 14(5):R206.
96. Clockaerts S., Van Osch G.J., Bastiaansen-Jenniskens Y.M., Verhaar J.A., Van Glabbeek F., Van Meurs J.B., et al. Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis 2012, 71(5):642-647.
97. Riddle D.L., Moxley G., Dumenci L. Associations between statin use and changes in pain, function and structural progression: a longitudinal study of persons with knee osteoarthritis. Ann Rheum Dis 2013, 72(2):196-203.
98. Kadam U.T., Blagojevic M., Belcher J. Statin use and clinical osteoarthritis in the general population: a longitudinal study. JGen Intern Med 2013, 28(7):943-949.
99. Belenchia A.M., Tosh A.K., Hillman L.S., Peterson C.A. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 2013, 97(4):774-781.
100. McAlindon T., LaValley M., Schneider E., Nuite M., Lee J.Y., Price L.L., et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013, 309(2):155-162.
101. Sanghi D., Mishra A., Sharma A.C., Singh A., Natu S.M., Agarwal S., et al. Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res 2013, 471(11):3556-3562.
102. Cao Y., Jones G., Cicuttini F., Winzenberg T., Wluka A., Sharman J., et al. Vitamin D supplementation in the management of knee osteoarthritis: study protocol for a randomized controlled trial. Trials 2012, 13:131.
103. Li X., Gibson G., Kim J.S., Kroin J., Xu S., van Wijnen A.J., et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 2011, 480(1-2):34-41.
104. Mazzetti I., Grigolo B., Pulsatelli L., Dolzani P., Silvestri T., Roseti L., et al. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci 2001, 101(6):593-599.
105. Davies C.M., Guilak F., Weinberg J.B., Fermor B. Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage 2008, 16(5):624-630.